AJMC Center for Biosimilars: How to Encourage Biosimilar Uptake, Cultural Changes and Formulary Placement
A deep dive into the future of biosimilars: In this In this exclusive 2-part video interview for AJMC’s Center for Biosimilars, editor Matthew Gavidia speaks with PRECISIONvalue’s Ryan Cox to discuss what employers can do to encourage biosimilar uptake, the cultural changes that are needed to make it happen, and whether midsize employers can participate in payer discussions on formulary placement.
Driving Value in the Era of Biosimilars – What Payers & Manufacturers Can Do to Support Employers
The complexities and misaligned incentives within our healthcare system have affected the pace of biosimilar adoption in the US.
Charting A Course Into The Unknown: Manufacturer Considerations In Gene Therapy
The gene therapy market is still in its infancy but poised for significant growth, with an approximate 25% increase in therapies in the pipeline as compared to 2018. However, the launch of a gene therapy is an event with limited case examples to follow and numerous unique considerations.
How the value of innovation will be redefined in 2021
The value of innovation in 2021: There will be a growing need for innovators to justify the value of their products to multiple stakeholders next year, with an increased focus on a treatment’s societal value, how innovation interacts with digital technologies, and whether new innovations are able to reduce existing health outcome inequalities.
The Importance of Crisis Management–Social Networking Strategies for Behavior Change in Vaccine Adoption
The Director-General of the World Health Organization recently declared that regarding COVID-19, “We’re not just fighting an epidemic; we’re fighting an infodemic.”
Webinar: Social Determinants of Health–Perspectives From the Academic, Provider, and Research Community
On-demand Webinar: Wish I Knew Then What I Know Now–How Cell and Gene Therapies are Reshaping Commercialization Strategies
In this webinar, Carolyn Morgan of PRECISIONeffect moderates an expert panel exploring the challenges of commercializing a cell or gene therapy from industry trailblazers.
Value Transformation: Observations on the Third Annual Evaluation Report of the Oncology Care Model
Contributor: Steps Health Professionals Can Take to Reduce Inequality in Health Outcomes
By Meena Venkatachalam, MSc , Jason Shafrin, PhD